Clinical Trials on Postmenopausal Disorder in France

Total 12660 results

University Hospital, Montpellier

Completed

Health Benefits of a 6-month Brisk Walking Program in Sedentary Postmenopausal Women (ACTIMARCH)

Sedentary Lifestyle | Postmenopausal Women

France
University Hospital, Toulouse

Completed

Effect of 17ß-estradiol on Inflammatory-immune Responses in Post-menopausal Women According to Administration Route

Postmenopausal

France
University Hospital, Lille

Recruiting

Bone Marrow Fat and Bariatric Surgery-Mediated Bone Loss (ADIMOS-OB)

Bariatric Surgery in Postmenopausal Women

France
Laboratoire des Adaptations Métaboliques à l'Exercice...
CREPS Auvergne Rhône-Alpes (AURA)

Completed

HIIT + RT on Body Composition and Gut Microbiota in Postmenopausal Women (PACWOMan) (PACWOMan)

Overweight | Postmenopausal Women

France
Sanofi
Procter and Gamble

Completed

Risedronate 75mg Dosed on 2 Consecutive Days Monthly in the Treatment of Osteoporosis in Postmenopausal Women

Osteoporosis Postmenopausal

France, United States, Australia, Canada, Lebanon, South Africa, Czech Republic, Turkey, Argentina, Poland, United Kingdom
Centre Hospitalier Régional Metz-Thionville

Completed

Psychological Determinants of the Therapeutic Observance of Osteoporotic Patients (OSTEOPSY)

Osteoporosis, Postmenopausal

France
University Hospital, Clermont-Ferrand

Recruiting

MAGnesium Effect With ANtiosteoporotic Drugs (MAGELLAN)

Osteoporosis, Postmenopausal

France
Laboratoire des Adaptations Métaboliques à l'Exercice...
CREPS Auvergne Rhône-Alpes / Vichy

Completed

Post Exercise Substrate Oxidation, Appetite and Energy Intakes in Overweight/Obese Postmenopausal Women (EScAPE) (EScAPE)

Overweight | Postmenopausal

France
Instituto de Cardiologia do Rio Grande do Sul

Not yet recruiting

Inspiratory Muscle Training X CardioBreath App Effects On Vagal Modulation And Pulse Wave Velocity (CardioBreath)

Vascular Stiffness | Autonomic Imbalance | Postmenopausal Disorder

Brazil
Amgen

Completed

Characteristics and Management of Postmenopausal Women With Osteoporosis Treated With Prolia® in France (PILOTE)

Post Menopausal Osteoporosis

France
Warner Chilcott

Completed

A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Estonia, Hungary, Poland, Canada, France, Argentina, Belgium
Warner Chilcott
Sanofi

Completed

A Study of Monthly Risedronate for Osteoporosis

Postmenopausal Osteoporosis

United States, Brazil, France, Spain, Hungary, Poland, Finland, Norway, Belgium, Argentina, Estonia, Lebanon, Canada, Australia
Instituto de Cardiologia do Rio Grande do Sul

Completed

Yoga Poses and Breath Control Cardiovascular Changes in Hypertensive Post-Menopause Women (YOGINI)

Hypertension | Postmenopausal Symptoms

Brazil
Solvay Pharmaceuticals

Completed

Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone Combination

Postmenopause

Croatia, France, Poland, Romania, Russian Federation
424 General Military Hospital

Recruiting

Single or Repeat Zoledronate Versus Alendronate Following Denosumab (EUROpean Denosumab Effects Consolidation Study) (EURODEC)

Osteoporosis, Postmenopausal

Greece, France, Germany, Italy
University Hospital, Clermont-Ferrand
Laboratory of metabolic adaptation to exercise under Physiological and Physiopathological...

Unknown

HIIE and Abdominal Fat Mass in DT2 Postmenopausal Women

Type 2 Diabetes | Postmenopausal Women | Overweight (BMI > 25)

France
Shire

Completed

TOP: Recombinant Human Parathyroid Hormone (ALX1-11) on Fracture Incidence in Women With Postmenopausal Osteoporosis

Osteoporosis

United States, Argentina, Canada, Brazil, Bulgaria, Israel, Mexico, Romania, Russian Federation
Denusa Wiltgen
Hospital de Clinicas de Porto Alegre; Coordenação de Aperfeiçoamento de Pessoal... and other collaborators

Completed

Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women

Postmenopause

Brazil
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Satisfaction in Women With Post-Menopausal Osteoporosis or Osteopenia

Postmenopausal Osteoporosis

United States
Sanofi
Procter and Gamble

Completed

OPTAMISE: Clinical Effectiveness of Teriparatide After Alendronate or Risedronate Therapy in Osteoporotic Postmenopausal Women

Osteoporosis, Postmenopausal

United States, Netherlands, Australia, Belgium, Canada, France, United Kingdom
Centre Hospitalier Universitaire de Saint Etienne
Ministry of Health, France

Recruiting

Study of the Impact of Mother-of-pearl Nutritional Supplementation on the Prevention of Post-menopausal Osteoporosis (NUTRANACRE)

Post Menopausal Osteoporosis

France
University Hospital, Clermont-Ferrand

Recruiting

Vascular Function, Sarcopenia and Pain in Postmenopausal Osteoporosis (VASCO)

Osteoporosis, Postmenopausal

France
Centre Francois Baclesse
National Cancer Institute, France; ARC Foundation for Cancer Research

Terminated

A Multicenter Trial Assessing the Efficacy and Safety of tamOxifen Plus LY2228820 in Advanced or Metastatic Breast Cancer Progressing on aromatasE Inhibitors (OLYMPE)

Metastatic Breast Cancer | Postmenopausal

France
Centre Hospitalier de Cayenne

Unknown

Autism Registry for French Guiana (REGUYAUT)

Autism Spectrum Disorder

France
Centre Hospitalier Universitaire de Besancon

Unknown

Effects of tDCS on Impulsiveness Among People Suffering From Borderline Personality Disorder (TIMBER)

Impulsive Behavior | Borderline Personality Disorder

France
Eli Lilly and Company

Completed

VERtebral Fracture Treatment Comparisons in Osteoporotic Women (VERO)

Postmenopausal Osteoporosis

United States, Germany, Hungary, Italy, Spain, Belgium, France, Poland, Austria, Canada, Puerto Rico, Argentina, Greece, Brazil, Czechia
Centre Hospitalier Universitaire de Besancon

Unknown

Access to Maternity and Risk Factors in a Non-consultant Population (PROXIMA)

Post Partum Depression

France
Eli Lilly and Company

Completed

Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis

Osteoporosis, Postmenopausal

Spain, United States, Taiwan, Italy, Argentina, Canada, France, Australia
Eli Lilly and Company

Completed

Comparison of Raloxifene Hydrochloride and Placebo in the Treatment of Postmenopausal Women With Osteoporosis (MORE)

Osteoporosis, Postmenopausal

Singapore, Canada, Mexico, Belgium, France, United States, Argentina, Australia, Austria, Czech Republic, Denmark, Finland, Germany, Hungary, Israel, Italy, Netherlands, New Zealand, Norway, Poland, Slovakia, Slovenia, Spain, Sweden, United...
Novo Nordisk A/S

Completed

Endometrial Safety of a Low Dose of Vagifem® in Postmenopausal Women With Atrophic Vaginitis

Menopause | Postmenopausal Vaginal Atrophy

France, Finland, Sweden, Denmark, Norway, Hungary, Czech Republic
Bayer
University of California, San Francisco; Laboratorium für Klinische Forschung; Diagnostic Cytology Laboratory

Completed

Endometrial Safety Study

Postmenopause

Mexico, United States, Italy, Denmark, Austria, Argentina, Brazil, Russian Federation
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Previously Treated With Bonviva

Post-Menopausal Osteoporosis

United States, Germany, United Kingdom, Spain, Italy, Hungary, Belgium, Mexico, Poland, Denmark, France, Norway, Brazil, Czechia
Hoffmann-La Roche

Completed

A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment

Post-Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, Italy, Belgium, United States, Poland, Denmark, Hungary, Czech Republic, France, Norway, United Kingdom, Australia
Amgen

Completed

Study to Determine the Efficacy and Safety of Romosozumab in the Treatment of Postmenopausal Women With Osteoporosis (ARCH)

Postmenopausal Women With Osteoporosis

United States, Canada, Denmark, France, Germany, Italy, Belgium, Colombia, Czechia, Mexico, Poland, Russian Federation, Netherlands, Hungary, Peru, Turkey, Taiwan, Spain, Hong Kong, Austria, Slovakia, United Kingdom, South Africa, Aus... and more
Novartis Pharmaceuticals

Completed

3 yr Efficacy & Safety Study of Zoledronic Acid in Post-menopausal Women With Osteoporosis Treated With Zol Acid for 6 Yrs

Post-menopausal Osteoporosis

Colombia, Belgium, Sweden, Hong Kong, United States, Hungary, Switzerland, Australia, Germany, Italy, Canada, Poland, Argentina, Thailand, Norway, New Zealand, France, Finland
Centre Hospitalier Universitaire de Besancon

Unknown

Development of a New Neuroimaging Method Aimed to Differentiate Mnesic Abilities of Alzheimer and Depressed Patients (RIHANNA)

Depression | Alzheimer Disease

France
Assistance Publique - Hôpitaux de Paris

Recruiting

Melatonin and Response to Lithium (MeLiR)

Bipolar Disorder I

France
University Hospital, Montpellier

Recruiting

Evaluation of a Parent/Child Cognitive-Behaviorial Therapy Program in ADHD Children With Emotional Dysregulation Profile (DP-KID)

Attention Deficit Disorder With Hyperactivity | Attention-Deficit-Disordered Children

France
Groupe Hospitalier Paris Saint Joseph

Completed

Implementation of a Tool on Alimentary Empowerment in New-born Baby

Neonatal Feeding Disorder

France
Hoffmann-La Roche

Completed

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

Post Menopausal Osteoporosis

Spain, South Africa, Germany, Mexico, United States, Canada, France, United Kingdom, Italy, Belgium, Australia, Poland, Denmark, Hungary, Czech Republic, Norway
Hoffmann-La Roche

Completed

A Study of Ibandronate (Boniva) to Evaluate Bone Turnover Markers in Women With Treatment-Naive Postmenopausal Osteoporosis

Post Menopausal Osteoporosis

United States, Puerto Rico
Centre Hospitalier Universitaire de Besancon

Terminated

Comparison Between High-density Electroencephalography and Conventional Electroencephalography for Comatose Patients (COMETIQUE)

Post Anoxic Coma

France
Hôpital le Vinatier

Unknown

tDCS as an add-on Treatment in SSRI-resistant OCD (TDCSTOC)

Obsessive-Compulsive Disorder

France
Institut National de la Santé Et de la Recherche...

Completed

Modification of Cerebral Activity of Obsessive Compulsive Disorder (OCD) Patients During Cognitive and Behavioral Therapy (TOC TOC)

Obsessive Compulsive Disorder

France
Janssen Research & Development, LLC

Completed

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Postmenopausal | Metastatic ER+ Her2- Breast Cancer

United States, France, Ukraine, United Kingdom, Belgium, Spain, Netherlands, Korea, Republic of, Russian Federation, Poland, Luxembourg, Ireland
Centre Hospitalier Henri Laborit

Recruiting

tDCS Associated With Symptom Provocation in the Management of Patients With Resistant Obsessive Compulsive Disorder (PPSTDCS-TOC)

Obsessive-Compulsive Disorder

France
Centre Hospitalier Universitaire de Nice

Recruiting

Study of the Effectiveness of Transcranial Direct Current Stimulation on Obsessive Compulsive Disorder (EFFI-STOC)

Obsessive-Compulsive Disorder

France
Nantes University Hospital
Roche Diagnostics

Recruiting

HE4 in the Diagnostic Approach of Endometrial Cancer in Patients With Postmenopausal Bleeding (METRODEC)

Endometrial Neoplasms | Uterine Hemorrhage | Postmenopause | Cancer Biomarker | CA 125 Antigen

France
Centre Hospitalier Henri Laborit

Recruiting

Cerebral and Cognitive Markers of Treatment Resistance in Obsessive Compulsive Disorder (3TOC)

OCD

France
Assistance Publique - Hôpitaux de Paris

Unknown

MetAbolism vaRiability of VEnLafaxine (MARVEL)

Major Depressive Disorders

France

Clinical Trials on Postmenopausal Disorder in France

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations